SECURITIES AND EXCHANGE COMMISSION



                             Washington, D.C.  20549



                                      FORM 8-K


                                   CURRENT REPORT



                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



                                     April 26, 2000




                                   Mallinckrodt Inc.
               (Exact name of registrant as specified in its charter)




          New York                1-483             36-1263901
(State or other jurisdiction     (Commission      (I.R.S. Employer
   of incorporation)              File Number)     Identification No.)



675 McDonnell Boulevard, St. Louis, MO                       63134
(Address of principal executive offices)                  (ZIP Code)


Registrant's telephone number,                         (314) 654-2000
    including area code



Item 5.  Other Events
A press release was issued April 26, 2000.  The relevant portion of
the text of that release was as follows:

MALLINCKRODT DIRECTORS APPOINT NEW BOARD MEMBER

ST. LOUIS, MO. - April 26, 2000 - Mallinckrodt Inc. (NYSE:MKG) said
today that Barry W. Wilson, Medtronic, Inc. senior vice president and
president, Europe, Middle East and Africa, will join its Board of
Directors, effective June 20, 2000. His nomination to a full three-
year term to the Mallinckrodt Board will be submitted to shareholders
at the company's annual meeting in October.

"Barry Wilson is a proven and respected international executive who
will bring outstanding medical products expertise to our highly
skilled and dedicated Board," said C. Ray Holman, Mallinckrodt
Chairman and Chief Executive Officer. "During his 33-year career in
the healthcare industry, he has had marketing, operations, business
development, product registration and general management
responsibilities spanning the globe. We are extremely pleased and
fortunate to have Barry join our Board."

Mr. Wilson, now based in Switzerland, was recruited by Medtronic in
1995 to build the company's therapeutical medical technology business
in Europe. Today, under his leadership as president of Europe, Middle
East and Africa, the business is $1 billion in sales and has 4,000
employees.

Prior to joining Medtronic, he spent two years as president of Lederle
International, a division of American Cyanamid. While there, he
assisted Wyeth International in post-acquisition integration after
American Home products bought American Cyanamid.

Wilson began his career with Pfizer, Inc. in 1967, and until 1980 held
a number of senior positions in marketing and brand and product
management in South Africa, Belgium, Germany, Hong Kong, Japan and
Korea.

In 1980, he joined Squibb Pacific in Hong Kong as vice president and
held a number of top management positions both in the United States
and internationally before being named president of Bristol-Myers
Squibb Intercontinental in 1989, after Squibb and Bristol-Myers
merged. He was named president of Bristol-Myers Squibb Europe in 1991.

Wilson, 55, is a native of England. He holds B.A. and M.A. degrees
from Cambridge University and received an M.B.A. in marketing from The
Wharton School, University of Pennsylvania, in 1967.

Mallinckrodt Inc. is a global manufacturer and marketer of specialty
medical products designed to sustain breathing, diagnose disease and
relieve pain. Named one of America's most admired medical products and
equipment companies by Fortune magazine, Mallinckrodt does business in
more than 100 countries. In fiscal 1999, combined net sales were $2.6
billion for Mallinckrodt's respiratory, imaging and pharmaceutical
product lines.


Mallinckrodt Inc.

/s/ Roger A. Keller
--------------------
ROGER A. KELLER
Vice President, Secretary
and General Counsel

DATE: June 21, 2000